Clinigen Group plc Issue of Equity (7209S)
October 04 2017 - 8:53AM
UK Regulatory
TIDMCLIN
RNS Number : 7209S
Clinigen Group plc
04 October 2017
4 October 2017
Issue of Equity
Clinigen Group plc (AIM: CLIN, the "Group") announces that it
has made an application for the admission to trading on AIM of
3,093 ordinary shares of 0.1 pence each in the Group (the "New
Ordinary Shares"), which have been issued to satisfy the exercise
of share options and rank pari passu with the existing shares of
the Group. Admission to trading on AIM of the New Ordinary Shares
is anticipated to occur on 9 October 2017.
At admission the issued share capital of the Group will consist
of 115,368,318 ordinary shares, with no shares held in treasury.
The total number of voting rights in the Group will therefore be
115,368,318. This figure may be used by shareholders as the
denominator to determine if they are required to notify their
interests in, or a change to their interests in, the Group under
the Disclosure Guidance and Transparency Rules.
-Ends-
Contact details
Clinigen Group plc Tel: +44 (0) 1283
495010
Shaun Chilton, Group Chief
Executive Officer
Martin Abell, Group Chief
Financial Officer
Numis Securities Limited Tel: +44 (0) 20
7260 1000
Michael Meade / Freddie Barnfield
(Nominated Adviser)
James Black / Tom Ballard
(Corporate Broking)
RBC Capital Markets - Joint Tel: +44 (0) 20
Broker 7653 4000
Marcus Jackson / Elliot Thomas
/ Jack Wood
Instinctif Partners Tel: +44 (0) 20
7457 2020
Melanie Toyne-Sewell / Alex
Shaw / Deborah Bell Email: clinigen@instinctif.com
About Clinigen Group
Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and
services company with a unique combination of businesses focused on
providing access to medicines. Its mission is to deliver the right
medicine to the right patient at the right time through three areas
of global medicine supply; clinical trial, unlicensed and licensed
medicines.
For more information, please visit www.clinigengroup.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEFSFFDLFWSEIS
(END) Dow Jones Newswires
October 04, 2017 09:53 ET (13:53 GMT)
Clinigen (LSE:CLIN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Clinigen (LSE:CLIN)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Clinigen Group Plc (London Stock Exchange): 0 recent articles
More Clinigen Group News Articles